Status:
WITHDRAWN
Facial Skin Health Tracking Feasibility in Breast Cancer Patients
Lead Sponsor:
University of Colorado, Denver
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
18+ years
Brief Summary
This feasibility study will assess if tracking objective and subjective facial skin changes over time is acceptable to pre and perimenopausal women undergoing chemotherapy and/or endocrine therapy for...
Detailed Description
There are no studies objectively assessing changes to facial skin health in this population, but tools exist to objectively measure changes thus we have chosen to use those tools to measure skin healt...
Eligibility Criteria
Inclusion
- Provision to sign and date the consent form
- Stated willingness to comply with all study procedures and be available for the duration of the study
- Be a pre or perimenopausal woman age 18 or over
- Be a patient with a new diagnosis of breast cancer who plans to undergo systemic chemotherapy or endocrine therapy, but who has not yet started treatment
Exclusion
- Postmenopausal status (one year without a menstrual period)
- Pregnant women (pregnancy test not required)
- Prior cancer diagnosis of any type other than breast cancer
- History of prior treatment with chemotherapy or radiation therapy
- Chronic skin disease including scleroderma, discoid lupus, atopic dermatitis, rosacea, eczema, or psoriasis
- Use of a retinoid-based prescription facial skin product within the past 11 month
Key Trial Info
Start Date :
January 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 13 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04035408
Start Date
January 24 2020
End Date
February 13 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Hospital
Aurora, Colorado, United States, 80045